These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17675483)

  • 1. Multiple constraints at the level of TCRalpha rearrangement impact Valpha14i NKT cell development.
    Hager E; Hawwari A; Matsuda JL; Krangel MS; Gapin L
    J Immunol; 2007 Aug; 179(4):2228-34. PubMed ID: 17675483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Valpha14i NKT cells.
    Schümann J; Pittoni P; Tonti E; Macdonald HR; Dellabona P; Casorati G
    J Immunol; 2005 Dec; 175(11):7303-10. PubMed ID: 16301636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors.
    Egawa T; Eberl G; Taniuchi I; Benlagha K; Geissmann F; Hennighausen L; Bendelac A; Littman DR
    Immunity; 2005 Jun; 22(6):705-16. PubMed ID: 15963785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms imposing the Vbeta bias of Valpha14 natural killer T cells and consequences for microbial glycolipid recognition.
    Wei DG; Curran SA; Savage PB; Teyton L; Bendelac A
    J Exp Med; 2006 May; 203(5):1197-207. PubMed ID: 16651387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mouse model for invariant NKT cell study.
    Wakao H; Kawamoto H; Sakata S; Inoue K; Ogura A; Wakao R; Oda A; Fujita H
    J Immunol; 2007 Sep; 179(6):3888-95. PubMed ID: 17785826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
    Sköld M; Faizunnessa NN; Wang CR; Cardell S
    J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting edge: influence of the TCR Vbeta domain on the selection of semi-invariant NKT cells by endogenous ligands.
    Schümann J; Mycko MP; Dellabona P; Casorati G; MacDonald HR
    J Immunol; 2006 Feb; 176(4):2064-8. PubMed ID: 16455960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DOCK2 is required in T cell precursors for development of Valpha14 NK T cells.
    Kunisaki Y; Tanaka Y; Sanui T; Inayoshi A; Noda M; Nakayama T; Harada M; Taniguchi M; Sasazuki T; Fukui Y
    J Immunol; 2006 Apr; 176(8):4640-5. PubMed ID: 16585555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of CD1d-restricted NKT cells in the mouse thymus.
    Dao T; Guo D; Ploss A; Stolzer A; Saylor C; Boursalian TE; Im JS; Sant'Angelo DB
    Eur J Immunol; 2004 Dec; 34(12):3542-52. PubMed ID: 15549774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR.
    Pyz E; Naidenko O; Miyake S; Yamamura T; Berberich I; Cardell S; Kronenberg M; Herrmann T
    J Immunol; 2006 Jun; 176(12):7447-55. PubMed ID: 16751390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the developmental status of Valpha14i NKT cells play a role in disease?
    Matsuda JL; Gapin L
    Int Rev Immunol; 2007; 26(1-2):5-29. PubMed ID: 17454262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell factor-1 controls the lifetime of CD4+ CD8+ thymocytes in vivo and distal T cell receptor α-chain rearrangement required for NKT cell development.
    Sharma A; Berga-Bolaños R; Sen JM
    PLoS One; 2014; 9(12):e115803. PubMed ID: 25536344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the complementarity-determining region 3 (CDR3) of the TCR-beta chains associated with the V alpha 14 semi-invariant TCR alpha-chain in the selection of CD4+ NK T Cells.
    Ronet C; Mempel M; Thieblemont N; Lehuen A; Kourilsky P; Gachelin G
    J Immunol; 2001 Feb; 166(3):1755-62. PubMed ID: 11160221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
    Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
    Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RORgammaT, a thymus-specific isoform of the orphan nuclear receptor RORgamma / TOR, is up-regulated by signaling through the pre-T cell receptor and binds to the TEA promoter.
    Villey I; de Chasseval R; de Villartay JP
    Eur J Immunol; 1999 Dec; 29(12):4072-80. PubMed ID: 10602018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical role for the T cell receptor alpha-chain connecting peptide domain in positive selection of CD1-independent NKT cells.
    Capone M; Troesch M; Eberl G; Hausmann B; Palmer E; MacDonald HR
    Eur J Immunol; 2001 Jun; 31(6):1867-75. PubMed ID: 11433383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invariant V alpha 14+ NKT cells participate in the early response to enteric Listeria monocytogenes infection.
    Ranson T; Bregenholt S; Lehuen A; Gaillot O; Leite-de-Moraes MC; Herbelin A; Berche P; Di Santo JP
    J Immunol; 2005 Jul; 175(2):1137-44. PubMed ID: 16002715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.